Q1 2025 · 13F-HR
venBio Partners LLCholdings as filed
Filed 2025-05-15 · accession 0000905148-25-001748
$123.6M
Reported value
7
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| N69605108 | PHVS | PHARVARIS N V | $67.3M | 54.5% | 4,289,304 | Common | SOLE |
| 022307102 | ALMS | ALUMIS INC | $17.1M | 13.9% | 2,787,398 | Common | SOLE |
| 413197104 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $16.2M | 13.1% | 489,194 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $9.4M | 7.61% | 3,806,410 | Common | SOLE |
| 00166B105 | ALXO | ALX ONCOLOGY HLDGS INC | $6.0M | 4.89% | 9,699,925 | Common | SOLE |
| 55083R104 | — | LYELL IMMUNOPHARMA INC | $3.8M | 3.09% | 7,102,190 | Common | SOLE |
| 04317A107 | ARTV | ARTIVA BIOTHERAPEUTICS INC | $3.6M | 2.91% | 1,198,975 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.